Metropolitan Life Insurance Company (MetLife)’s Plantronics, Inc. POLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,745
| Closed | -$109K | – | 2388 |
|
|
2022
Q2 | $109K | Hold |
2,745
| – | – | ﹤0.01% | 1012 |
|
|
2022
Q1 | $108K | Sell |
2,745
-8,387
| -75% | -$239K | ﹤0.01% | 1149 |
|
|
2021
Q4 | $327K | Hold |
11,132
| – | – | ﹤0.01% | 1697 |
|
|
2021
Q3 | $286K | Buy |
11,132
+2,018
| +22% | +$63.3K | ﹤0.01% | 1815 |
|
|
2021
Q2 | $380K | Sell |
9,114
-1,189
| -12% | -$44.4K | 0.01% | 1698 |
|
|
2021
Q1 | $401K | Sell |
10,303
-281
| -3% | -$10.6K | 0.01% | 1552 |
|
|
2020
Q4 | $286K | Hold |
10,584
| – | – | ﹤0.01% | 1703 |
|
|
2020
Q3 | $125K | Hold |
10,584
| – | – | ﹤0.01% | 2088 |
|
|
2020
Q2 | $155K | Hold |
10,584
| – | – | ﹤0.01% | 1983 |
|
|
2020
Q1 | $106K | Buy |
10,584
+301
| +3% | +$5.62K | ﹤0.01% | 1998 |
|
|
2019
Q4 | $281K | Sell |
10,283
-8,807
| -46% | -$265K | ﹤0.01% | 1683 |
|
|
2019
Q3 | $712K | Sell |
19,090
-312
| -2% | -$10.6K | 0.01% | 1070 |
|
|
2019
Q2 | $719K | Buy |
19,402
+13
| +0.1% | +$603 | 0.01% | 1085 |
|
|
2019
Q1 | $894K | Sell |
19,389
-75
| -0.4% | -$3.27K | 0.02% | 943 |
|
|
2018
Q4 | $644K | Buy |
19,464
+40
| +0.2% | +$1.98K | 0.01% | 1055 |
|
|
2018
Q3 | $1.17M | Sell |
19,424
-93
| -0.5% | -$6.36K | 0.02% | 847 |
|
|
2018
Q2 | $1.49M | Buy |
19,517
+339
| +2% | +$23.4K | 0.02% | 700 |
|
|
2018
Q1 | $1.16M | Buy |
19,178
+98
| +0.5% | +$5.47K | 0.02% | 833 |
|
|
2017
Q4 | $961K | Sell |
19,080
-34,074
| -64% | -$1.67M | 0.01% | 914 |
|
|
2017
Q3 | $2.35M | Buy |
53,154
+49
| +0.1% | +$2.25K | 0.01% | 889 |
|
|
2017
Q2 | $2.78M | Buy |
53,105
+585
| +1% | +$31.5K | 0.02% | 856 |
|
|
2017
Q1 | $2.84M | Sell |
52,520
-681
| -1% | -$37.1K | 0.02% | 841 |
|
|
2016
Q4 | $2.91M | Sell |
53,201
-1
| -0% | -$52 | 0.02% | 830 |
|
|
2016
Q3 | $2.76M | Sell |
53,202
-729
| -1% | -$35.8K | 0.02% | 829 |
|
|
2016
Q2 | $2.37M | Sell |
53,931
-1,403
| -3% | -$58.5K | 0.02% | 874 |
|
|
2016
Q1 | $2.17M | Buy |
55,334
+756
| +1% | +$29.6K | 0.02% | 864 |
|
|
2015
Q4 | $2.59M | Buy |
54,578
+566
| +1% | +$29.3K | 0.02% | 799 |
|
|
2015
Q3 | $2.75M | Sell |
54,012
-7,479
| -12% | -$409K | 0.02% | 776 |
|
|
2015
Q2 | $3.46M | Buy |
+61,491
| New | +$3.43M | 0.02% | 732 |
|
|
2015
Q1 | – | Sell |
-67,921
| Closed | -$3.6M | – | 2499 |
|
|
2014
Q4 | $3.6M | Buy |
67,921
+383
| +0.6% | +$19.3K | 0.02% | 703 |
|
|
2014
Q3 | $3.23M | Buy |
67,538
+482
| +0.7% | +$23.1K | 0.02% | 719 |
|
|
2014
Q2 | $3.22M | Sell |
67,056
-1,889
| -3% | -$84.1K | 0.02% | 768 |
|
|
2014
Q1 | $3.06M | Buy |
68,945
+68
| +0.1% | +$3K | 0.02% | 774 |
|
|
2013
Q4 | $3.2M | Buy |
68,877
+80
| +0.1% | +$3.61K | 0.02% | 734 |
|
|
2013
Q3 | $3.17M | Buy |
68,797
+883
| +1% | +$40.4K | 0.02% | 699 |
|
|
2013
Q2 | $2.98M | Buy |
+67,914
| New | +$3.04M | 0.02% | 690 |
|
Other funds holding POLY
Metropolitan Life Insurance Company (MetLife)'s POLY Position: Q3 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Plantronics, Inc. (POLY) in Q3 2022, closing a stake of 2,745 shares — an estimated $109K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in POLY in Q2 2013 and held it in 36 quarters. The position peaked at $3.6M in Q4 2014. 2 funds tracked by Wall St. Rank hold POLY as of Q3 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Plantronics, Inc. position as of Q3 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,745 Plantronics, Inc. shares in Q3 2022, an estimated $109K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Plantronics, Inc. in Q2 2013 and held it in 36 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Plantronics, Inc. position peaked at $3.6M in Q4 2014.
- 2 funds tracked by Wall St. Rank held Plantronics, Inc. as of Q3 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.